RECONCILIATION OF DILUTED NET INCOME (LOSS) PER SHARE TO ADJUSTED INCOME PER DILUTED SHARE ("ADJUSTED EPS")
(in thousands, except per share data)
(Unaudited)
Three Months
Ended March 31,
2024
Weighted average diluted shares outstanding
83,275
Net income and diluted income per share
$
4,035
$
0.05
Adjustments (1):
Amortization (net of tax of $863)
2,589
0.03
Stock-based compensation (net of tax of $716)
2,146
0.03
Transformational and restructuring expenses (net of tax of $2,120)
6,360
0.08
Net impact from discrete tax events
1,676
0.01
Adjusted income and diluted EPS
$
16,806
$
0.20
(1)A blended tax rate of 25% was used to calculate the tax effects of the adjustments.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Pediatrix Medical Group Inc. published this content on
07 May 2024 and is solely responsible for the information contained therein. Distributed by
Public, unedited and unaltered, on
07 May 2024 10:10:45 UTC.
Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Companyâs affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. Its national network comprises over 2,620 affiliated physicians, including 1,330 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 580 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
PEDIATRIX MEDICAL GROUP, INC. 
